ArticleBMC health services research2026
Bridging the rural logistics penalty: quantifying structural costs and designing policy mechanisms for home TCM delivery to older adults with chronic respiratory diseases.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEquitable access to prescribed therapies remains challenging for older adults with chronic respiratory diseases (CRDs) in rural China. Liquid Traditional Chinese Medicine (TCM) decoctions are widely used in respiratory care, but their large volume, thermal sensitivity, and need for temperature-controlled handling make home delivery particularly difficult in geographically dispersed rural settings. The structural and cost implications of this rural cold-chain delivery burden remain insufficiently quantified.
methodsWe developed a four-stage calibrated simulation framework linking CHARLS 2018 microdata with external facility-density statistics, interpretable machine learning, parameterized micro-costing, and policy scenario modelling. The analytic sample included 11,045 adults aged ≥ 60 years, including 2,351 participants with chronic lung disease or asthma. Because CHARLS does not provide patient-level geocoded coordinates or observed residence-to-facility routes, Stage I generated simulation-derived distance distributions rather than observed travel distances, and no patient-level geocoded empirical validation was possible. Stage II used an IADL-based XGBoost-SHAP model to characterize functional vulnerability more directly relevant to medication access and home-delivery prioritization, with ADL retained as a sensitivity outcome. Stage III estimated cold-chain delivery costs under alternative assumptions for consolidation, route tortuosity, and willingness to pay. Stage IV examined cooperation dynamics across subsidy scenarios.
resultsThe calibrated simulation preserved the facility-density-driven rural-urban contrast by design rather than empirically discovering patient routes. Mean modeled distance was 10.61 km for rural residents versus 2.85 km for urban residents, and 10.8% of rural simulated observations exceeded 15 km. The IADL-based XGBoost model achieved an AUC of 0.668 and an accuracy of 0.631; rural residence ranked eighth and was not the leading predictor in the service-vulnerability model. Rural delivery costs exceeded urban benchmarks under all modeled scenarios, with the rural 95th percentile ranging from 34.28 RMB at η = 10 to 77.63 RMB at η = 3. Higher subsidy, willingness to pay, and consolidation efficiency increased cooperation levels, but no scanned condition produced stable three-party cooperation within the 35-55 RMB subsidy range.
conclusionsThis study provides a transparent calibrated-simulation stress test rather than an empirically validated route-reconstruction or subsidy-threshold study. Under the current assumptions, the findings do not support a single transferable subsidy threshold and instead indicate that local pilot calibration, observed route-cost data, and realistic payoff inputs are required before implementation claims can be made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.